Forum Member Register/Login
Forums
Category Archives: Cell
Cholesterol accumulates within cells
Cholesterol accumulates within cells
1. atherosclerosis
2. xanthomas
3. inflammation and necrosis (foamy mφ)
4. cholesterolosis
5. Niemann-Pick disease
Robbins Basic Pathology 7th ed, edited by Vinay Kumar, Ramzi S. Cotran, and Stanley J. Robbins, 873 pp, Philadelphia, Pa, Sounders, 2003.
Posted in Cell
Tagged , atherosclerosis, cholesteraol, cholesterolosis, foamy macrophages, inflammation and necrosis, Niemann-Pick disease, xanthoma
Comments Off
Nucleolar organizer regions
Nucleolar organizer regions
- Correlation between counts of silver-staining NORs (AgNORs) and other cell proliferation indices
- May not be reliable because counts influenced by variations in ploidy and transcriptional activity
Posted in Cell
Tagged , Cell proliferation, Cell proliferation measurement, DNA flow cytometry, Flow cytometry, Measuring cell proliferation, Measuring mitotic rate, Mitotic count, Nucleolar organizer regions
Comments Off
MIB-1
MIB-1
o Determines proliferative fraction of tumour cell populations
o Strong immunoreactivity, however allows for recognition of cellular details and therefore better identification of positive cellular subsets
o No sophisticated technical skill needed to apply technique
o May have interobserver variability
Posted in Cell
Tagged , Cell proliferation, Cell proliferation measurement, DNA flow cytometry, Flow cytometry, Measuring cell proliferation, Measuring mitotic rate, MIB-1, MIB1, Mitotic count
Comments Off
Ki-67
Ki-67
o Expressed in all phases except G0 and early G1; provides a measure of tumour proliferative fraction
o No sophisticated technical skill needed to apply technique
o May have interobserver variability
Posted in Cell
Tagged , Cell proliferation, Cell proliferation measurement, DNA flow cytometry, Flow cytometry, Ki-67, Ki-67 Pathology, Ki67, Measuring cell proliferation, Measuring mitotic rate, Mitotic count
Comments Off
Iododeoxyuridine bromodeoxyuridine labeling
Iododeoxyuridine bromodeoxyuridine labeling
- Provides cell kinetic information on human tumours (eg. DNA synthesis time, potential tumour doubling time)
- Immunoperoxidase techniques can be used concurrently to determine proliferation on tumour proliferation heterogeneity at microscopic level
- Provides averaged values, therefore sacrificing information on tissue spatial distribution of proliferation
DNA flow cytometry
DNA flow cytometry
- Has advantage of speed and statistical precision (10, 000-100,000 cells can be analyzed in a few minutes or less)
- Multiple parameters can be examined
- Requires expensive apparatus
- Fresh tissue must be disaggregated which may be difficult; small samples not useful to analyze in this manner since tissue morphology lost through this technique
Posted in Cell
Tagged , Cell proliferation, Cell proliferation measurement, DNA flow cytometry, Flow cytometry, Measuring cell proliferation, Measuring mitotic rate, Mitotic count
Comments Off
Thymidine labeling
Thymidine labeling
- Only cells actively synthesizing DNA (ie. in S-phase) will incorporate tritiated thymidine into DNA during pulse labeling; pulse-labelling with tritiated thymidine regarded as functional marker of proliferative activity; reflects fraction of S-phase cells
- Requires in vivo administration of tritiated thymidine or incubation of fresh tissue in vitro prior to fixation; makes it impractical for clinical use. Requires autoradiography; time-consuming; not practical.
- Does not measure duration of S-phase, so it is possible for a tumour to have a slow proliferation rate but a high thymidine labeling index
- Dependent on tumour sampling
- Involves cell counting; prone to interobserver variation, reproducibility error and variations in sample size
Posted in Cell
Tagged , Cell proliferation, Cell proliferation measurement, Measuring cell proliferation, Measuring cell replication, Measuring mitoses, Measuring mitosis, Mitosis, Mitotic count, Mitotic rate, Thymidine, Thymidine label, Thymidine labeling
Comments Off
Mitotic count
Mitotic count
Most convenient, most widely method used in clinical practice to give first impression of proliferative activity
Defined as number of mitoses/10 HPF
Validity of mitotic count as marker of tumour proliferative activity remains controversial; not standardized, takes no account of cell size; area of single HPF may vary up to 6-fold between different microscopes
Subject to interobserver variation
Posted in Cell
Tagged , Cell proliferation, Cell proliferation measurement, Measuring cell proliferation, Measuring cell replication, Measuring mitoses, Measuring mitosis, Mitosis, Mitotic count, Mitotic rate
Comments Off
Cell Cycle
Cell cycle
The phases of the cell cycle
• G0
• G1
• S
• G2
• M
Cyclin Dependent Kinase
• Cyclin Dependent Kinases allow for the progression of the cell through various phases of the cell cycle by activating cyclin dependent kinases (CDKs)
• Cyclins are synthesized during certain phases of the cell cycle, phosphorylate constitutively produced CDKs to activate them and their levels subsequently decline
• Activated CDKs phosphorylate target proteins required for the progression of the cell to the next phase of the cell cycle
c) Desribe the role of RB protein
• RB prevents the cell from entering S phase until certain cellular signals are met
• Hypophosphorylated RB is bound to E2F (a transcription factor) and prevents its activity since RB recruits histone deacetylase, causing compaction of chromatin and inhibiting transcription
• Growth factors cause the concentrations of cyclins D and E to go up, thereby activating cyclin D-CDK4 and cyclin E-CDK2, which then phosphorylate RB
• Phosphorylation of RB releases it from its complex with E2F, allowing E2F to transcribe key cell cycle proteins such as thymidine kinase, DNA polymerases, cyclin E and dihydrofolate reductase, allowing the cell to transition from G1 to S phase
• During the M phase, RB is converted to its hypophosphorylated form by cellular phosphatases
Cell Cycle Gene Mutations and Cancer
• Mutations that activate oncogenes (eg. Her2-neu, EGFR, KIT, BRAF, β-catenin, RAS, MYC, RET, Cyclin D1)
• Mutations that inactivate tumour suppressor genes (eg. RB, p53, BRCA1, BRCA2, E-cadherin, NF-1, NF-2, APC/ β-catenin, WT-1, p16/INK4)
• Mutations of DNA repair genes (hMLH1, hMSH2, PMS1, PMS2, ATM)
• Alterations of genes involved in apoptosis (eg. BCL-2, p53, MYC)
Posted in Cell
Tagged , Cell Cycle, Cell cycle cancer, Cell cycle cyclins, Cell cycle gene, Cell cycle mutations, Cell cycle phases, Cyclin, Cyclin dependent kinase
Comments Off